Registration
BOOK HILL PARTNERS for CLEVELAND BIOLABS
Firm
Client
Income
—
Expenses
—
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Biodefense and health
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT F HOUSMAN New | Asst. Dir. White House Drug Policy Office |
| RICK MOORE New | — |
| ERIC VAUGHN New | Special Asst, Dir. OMB |
Health Issues HCR
Biodefense and health
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT F HOUSMAN New | Asst. Dir. White House Drug Policy Office |
| RICK MOORE New | — |
| ERIC VAUGHN New | Special Asst, Dir. OMB |
Pharmacy PHA
Biodefense and health
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT F HOUSMAN New | Asst. Dir. White House Drug Policy Office |
| RICK MOORE New | — |
| ERIC VAUGHN New | Special Asst, Dir. OMB |
Homeland Security HOM
Biodefense and health
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT F HOUSMAN New | Asst. Dir. White House Drug Policy Office |
| RICK MOORE New | — |
| ERIC VAUGHN New | Special Asst, Dir. OMB |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.